These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 3079801)

  • 1. Modulation of the population density of identifiable epidermal Langerhans cells associated with enhancement or suppression of cutaneous immune reactivity.
    Rheins LA; Nordlund JJ
    J Immunol; 1986 Feb; 136(3):867-76. PubMed ID: 3079801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between keratinocyte expression of Ia and the intensity and duration of contact hypersensitivity responses in mice.
    Roberts LK; Spangrude GJ; Daynes RA; Krueger GG
    J Immunol; 1985 Nov; 135(5):2929-36. PubMed ID: 3862711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB.
    Toews GB; Bergstresser PR; Streilein JW
    J Immunol; 1980 Jan; 124(1):445-53. PubMed ID: 6153101
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between epidermal Langerhans cell density ATPase activity and the induction of contact hypersensitivity.
    Lynch DH; Gurish MF; Daynes RA
    J Immunol; 1981 May; 126(5):1892-7. PubMed ID: 6452479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid induction of Thy-1 antigenic markers on keratinocytes and epidermal immune cells in the skin of mice following topical treatment with common preservatives used in topical medications and in foods.
    Rheins LA; Young EM; Nordlund ML; Berning RB; Nordlund JJ
    J Invest Dermatol; 1987 Nov; 89(5):489-94. PubMed ID: 2889782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity.
    Girolomoni G; Pastore S; Zacchi V; Cavani A; Marconi A; Giannetti A
    J Immunol; 1993 May; 150(10):4236-43. PubMed ID: 8482834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of systemic immune suppression by UV irradiation in vivo. II. The UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies.
    Noonan FP; Bucana C; Sauder DN; De Fabo EC
    J Immunol; 1984 May; 132(5):2408-16. PubMed ID: 6232317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
    Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
    J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity.
    Bacci S; Alard P; Dai R; Nakamura T; Streilein JW
    Eur J Immunol; 1997 Feb; 27(2):442-8. PubMed ID: 9045915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis.
    Halliday GM; Lucas AD
    Immunology; 1993 Aug; 79(4):621-6. PubMed ID: 8406587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active induction of unresponsiveness (tolerance) to DNFB by in vivo ultraviolet-exposed epidermal cells is dependent upon infiltrating class II MHC+ CD11bbright monocytic/macrophagic cells.
    Hammerberg C; Duraiswamy N; Cooper KD
    J Immunol; 1994 Dec; 153(11):4915-24. PubMed ID: 7963554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the cutaneous immune response following topical application of the prostaglandin PGE2.
    Rheins LA; Barnes L; Amornsiripanitch S; Collins CE; Nordlund JJ
    Cell Immunol; 1987 Apr; 106(1):33-42. PubMed ID: 2952282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells.
    Aberer W; Romani N; Elbe A; Stingl G
    J Immunol; 1986 Feb; 136(4):1210-6. PubMed ID: 2868057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.
    Palkowski MR; Nordlund ML; Rheins LA; Nordlund JJ
    Arch Dermatol; 1987 Aug; 123(8):1022-8. PubMed ID: 2443080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies.
    Ray MC; Tharp MD; Sullivan TJ; Tigelaar RE
    J Immunol; 1983 Sep; 131(3):1096-102. PubMed ID: 6193174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the contact hypersensitivity response following topical exposure to 2-butoxyethanol in female BALB/c mice.
    Singh P; Morris B; Zhao S; Blaylock BL
    Int J Toxicol; 2002; 21(2):107-14. PubMed ID: 12022630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice.
    Wang B; Zhuang L; Fujisawa H; Shinder GA; Feliciani C; Shivji GM; Suzuki H; Amerio P; Toto P; Sauder DN
    J Immunol; 1999 Jan; 162(1):277-83. PubMed ID: 9886396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells.
    Suzuki H; Wang B; Shivji GM; Toto P; Amerio P; Tomai MA; Miller RL; Sauder DN
    J Invest Dermatol; 2000 Jan; 114(1):135-41. PubMed ID: 10620129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.